Speaking of Argo, from their email this morning: Botanix is...

Speaking of Argo, from their email this morning:

Botanix is positioning itself at the forefront of a new regime of pharmacological derma treatments.
It should not be viewed as a one trick pony in the medicinal cannabis space.
Management have very astutely “ring fenced” each of its products by making variations in the formulation and delivery (eg for acne it’s a gel and AD is a pump spray).
This will give BOT the ability to monetise the products individually, that is, not selling the farm, just selling it paddock by paddock.
Remarkably we have an Australian biotech leading the race globally to find new treatments for a range of skin conditions that have serious unmet needs and no new products for a generation.
Again, referring to the presentation we can see substantial news flow for the rest of this year.
Post its recent successful capital raising Botanix is well funded to execute its ambitious plans.

Regarding the above mentioned presentation, it may be released soon so let me just say that, as per usual with Botanix, it looks sharp, it looks professional and it underscores the enormous potential of this company.